Insider · CIK 0002041855

Davis Gregory D

Reports to the SEC for 1 company · RICHMOND, CA

sec.gov

Transactions

Companies

Filings

CIK

0002041855

Forms 4 and 5

Insider transactions

19 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−1,630 sh	$0.17	−$284.109	113,654
2026-04-22	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Head of Research & Technology	SSale	−69.8K sh	$0.25	−$17.7K	115,284
2026-04-01	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Head of Research & Technology	AAward	+225K sh	—	—	225,000
2026-02-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−5,119 sh	$0.47	−$2,405.93	185,111
2026-02-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−832 sh	$0.47	−$393.12	190,230
2026-01-22	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−7,721 sh	$0.40	−$3,076.819	191,062
2025-11-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−723 sh	$0.42	−$301.202	193,791
2025-10-22	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−6,708 sh	$0.66	−$4,427.28	194,514
2025-08-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−723 sh	$0.59	−$423.895	201,222
2025-07-22	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−6,708 sh	$0.48	−$3,218.498	201,945
2025-05-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−723 sh	$0.47	−$342.196	208,653
2025-04-22	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−6,708 sh	$0.78	−$5,207.42	209,376
2025-02-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−507 sh	$0.96	−$484.743	166,358
2025-02-25	SGMOQSANGAMO THERAPEUTICS, INCA Award	Head of Research & Technology	AAward	+49.7K sh	—	—	216,084
2025-02-25	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Head of Research & Technology	AAward	+99.5K sh	—	—	99,454
2025-02-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−705 sh	$1.00	−$705	166,865
2025-01-22	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−30.5K sh	$1.15	−$35K	167,570
2024-11-25	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−505 sh	$1.94	−$979.7	201,863
2024-11-24	SGMOQSANGAMO THERAPEUTICS, INCF Tax Payment	Head of Research & Technology	FTax Payment	−721 sh	$1.88	−$1,355.48	202,368

Recent filings

Accepted (ET)
May 274
Davis Gregory D0002041855-26-000010
SEC(opens sec.gov)
Apr 234
Davis Gregory D0002041855-26-000008
SEC(opens sec.gov)
Apr 34
Davis Gregory D0002041855-26-000006
SEC(opens sec.gov)
Feb 264
Davis Gregory D0002041855-26-000004
SEC(opens sec.gov)
Jan 264
Davis Gregory D0002041855-26-000002
SEC(opens sec.gov)
Nov 264
Davis Gregory D0002041855-25-000006
SEC(opens sec.gov)
Oct 244
Davis Gregory D0002041855-25-000004
SEC(opens sec.gov)
Aug 264
Davis Gregory D0001415889-25-023079
SEC(opens sec.gov)
Jul 244
Davis Gregory D0001415889-25-020242
SEC(opens sec.gov)
May 284
Davis Gregory D0001415889-25-014696
SEC(opens sec.gov)
Apr 244
Davis Gregory D0001415889-25-011279
SEC(opens sec.gov)
Feb 264
Davis Gregory D0001415889-25-005708
SEC(opens sec.gov)
Jan 244
Davis Gregory D0001415889-25-002022
SEC(opens sec.gov)
Nov 264
Davis Gregory D0001415889-24-027707
SEC(opens sec.gov)

Companies

SANGAMO THERAPEUTICS, INCHead of Research & TechnologySGMOQ

Address

C/O SANGAMO THERAPEUTICS, INC. 501 CANAL BLVD.

RICHMOND, CA, 94804